Molecular and cellular effects of NEDD8-activating enzyme inhibition in myeloma. (Q37127019)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22246439%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

title

Molecular and cellular effects of NEDD8-activating enzyme inhibition in myeloma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22246439%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22246439%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Andrew L. Kung

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22246439%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

10

Kenneth C Anderson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22246439%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

9

Paul G Richardson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22246439%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

3

Jake E Delmore

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22246439%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

2

Hannah M Jacobs

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22246439%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Constantine S Mitsiades

13

object named as

Constantine S Mitsiades

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22246439%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

11

Steven P Treon

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22246439%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

4

Leutz Buon

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22246439%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Douglas W McMillin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22246439%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Val Monrose

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22246439%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Jie Yu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22246439%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Peter G Smith

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22246439%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

language of work or name

1 reference

12 January 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22246439%20AND%20SRC:MED&resulttype=core&format=json

Molecular Cancer Therapeutics

20 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22246439%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22246439%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22246439%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

942-951

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22246439%20AND%20SRC:MED&resulttype=core&format=json

The NEDD8 Conjugation Pathway and Its Relevance in Cancer Biology and Therapy

20 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755358

Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755358

Inhibition of NEDD8-activating enzyme: a novel approach for the treatment of acute myeloid leukemia.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755358

An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755358

Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755358

The molecular classification of multiple myeloma

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755358

Transcriptional signature of histone deacetylase inhibition in multiple myeloma: biological and clinical implications

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755358

Molecular sequelae of proteasome inhibition in human multiple myeloma cells

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755358

Proteasome inhibitors: a novel class of potent and effective antitumor agents.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755358

MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-{kappa}B-dependent lymphoma

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755358

Targeting NEDD8-activated cullin-RING ligases for the treatment of cancer.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755358

Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755358

Bortezomib or high-dose dexamethasone for relapsed multiple myeloma

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755358

Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755358

TRAIL/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755358

High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755358

Fluorescence imaging of multiple myeloma cells in a clinically relevant SCID/NOD in vivo model: biologic and clinical implications

4 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22246439

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22246439

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1158/1535-7163.MCT-11-0563

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22246439%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22246439%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

PubMed publication ID

22246439

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22246439%20AND%20SRC:MED&resulttype=core&format=json